Respiratory Complications After Laparoscopic Surgery

Sponsor
Herlev Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01476254
Collaborator
(none)
60
2
12
30
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to describe the magnitude of respiratory complications after laparoscopic hysterectomy and cholecystectomy.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The purpose of this study is to describe change in pulmonary function and incidence of respiratory complications after laparoscopic surgery.

    The investigators will include 60 women scheduled for laparoscopic hysterectomy or cholecystectomy. The investigators will measure the pulmonary function by different methods during and for 2 hours after surgery. Moreover, the incidence of respiratory complications including pneumonia, respiratory failure and radiologically verified atelectasis will be registered.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    60 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Respiratory Complications After Laparoscopic Surgery
    Study Start Date :
    Nov 1, 2011
    Actual Primary Completion Date :
    Nov 1, 2012
    Actual Study Completion Date :
    Nov 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    Cholecystectomy

    Women scheduled for laparoscopic cholecystectomy

    Hysterectomy

    Women scheduled for laparoscopic hysterectomy

    Outcome Measures

    Primary Outcome Measures

    1. Arterial oxygen tension 2 hours after surgery [2 hours after end of surgery]

      Change in arterial oxygen tension 2 hours after surgery

    Secondary Outcome Measures

    1. Oxygenation index 2 hours after surgery [2 hours after end of surgery]

      Change in oxygenation index (PaO2/FiO2) 2 hours after surgery

    2. FEV1 and FVC 2 hours after surgery [2 hours after end of surgery]

      Change in FEV1 and FVC 2 hours after surgery

    3. Pulmonary shunt 2 hours after surgery [2 hours after end of surgery]

      Change in pulmonary shunt 2 hours after surgery

    4. Ventilation-perfusion ratio 2 hours after surgery [2 hours after end of surgery]

      Change in ventilation-perfusion ratio from baseline to 2 hours after surgery

    5. Arterial oxygen saturation 2 hours after surgery [2 hours after surgery]

      Change in arterial oxygen saturation 2 hours after surgery

    6. Respiratory frequency 2 hours after surgery [2 hours after surgery]

      Change in respiratory frequency 2 hours after surgery

    7. Oxygen supplement at discharge from the postanesthesia care unit [At discharge from the postanesthesia care unit, which will be approximately 2 hours after surgery]

      The proportion of patients who received oxygen supplement at discharge from the postanesthesia care unit in order keep arterial oxygen saturation above 93%

    8. Connection between pulmonary shunt and need for oxygen supplement [2 hours postoperatively and at discharge from the postanesthesia care unit]

      The connection between pulmonary shunt 2 hours after surgery and need for oxygen supplement at discharge from the postanesthesia department in order to keep peripheral oxygen saturation above 93%.

    9. FEV1 and FVC 24 hours after surgery [24 hours after surgery]

      Change in FEV1 and FVC 24 hours after surgery

    10. Pulmonary shunt 24 hours after surgery [24 hours after surgery]

      Change in pulmonary shunt 24 hours after surgery

    11. Ventilation-perfusion ratio 24 hours after surgery [24 hours after surgery]

      Change in ventilation-perfusion ratio 24 hours after surgery

    12. Arterial oxygen saturation 24 hours after surgery [24 hours after surgery]

      Change in arterial oxygen saturation 24 hours after surgery

    13. Respiratory frequency 24 hours after surgery [24 hours after surgery]

      Change in respiratory frequency 24 hours after surgery

    14. Length of stay [Participants will be followed for the duration of hospital stay, an expected average of 3 days]

      Length of stay at the hospital

    15. Pneumonia [Participants will be followed for the duration of hospital stay, an expected average of 3 days]

      Incidence of pneumonia from surgery to discharge from hospital

    16. Respiratory failure after surgery [Participants will be followed for the duration of hospital stay, an expected average of 3 days]

      Incidence of respiratory failure from surgery to discharge from hospital

    17. Atelectasis [Participants will be followed for the duration of hospital stay, an expected average of 3 days]

      Incidence of radiologically verified atelectasis from surgery to discharge from hospital

    18. High temperature [Participants will be followed for the duration of hospital stay, an expected average of 3 days]

      Incidence of a high temperature ( above 38 degrees celsius) from surgery to discharge from hospital

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women

    • 45 years old

    • Scheduled for laparoscopic cholecystectomy or laparoscopic hysterectomy

    Exclusion Criteria:
    • Weight < 50 kg

    • Pregnant or nursing

    • Cardiac failure

    • Renal failure

    • Inability to breath through a facial mask

    • Inability to give informed consent

    • Inability to keep arterial oxygen saturation above 90% without supplemental oxygen

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Anesthesia, Herlev Hospital Herlev Denmark 2730
    2 Department of Anesthesia, Hillerød Hospital Hillerød Denmark 3400

    Sponsors and Collaborators

    • Herlev Hospital

    Investigators

    • Study Chair: Mona R Gätke, M.D. Ph.D., Department of Anesthesia, Herlev Hospital, University of Copenhagen
    • Principal Investigator: Anne K Staehr, M.D., Department of Anesthesia, Herlev Hospital, University of Copenhagen

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Anne Kathrine Staehr, Research Assistant, Herlev Hospital
    ClinicalTrials.gov Identifier:
    NCT01476254
    Other Study ID Numbers:
    • RESP-1
    First Posted:
    Nov 22, 2011
    Last Update Posted:
    Nov 20, 2012
    Last Verified:
    Nov 1, 2012
    Keywords provided by Anne Kathrine Staehr, Research Assistant, Herlev Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 20, 2012